| 1 | BLS2B, RFXANK
|
| Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.
|
| Ouederni M, Vincent QB, Frange P, Touzot F, Scerra S, Bejaoui M, Bousfiha A, Levy Y, Lisowska-Grospierre B, Canioni D, Bruneau J, Debré M, Blanche S, Abel L, Casanova JL, Fischer A, Picard C.
|
| Blood 118(19):5108-18. Epub 2011 Sep 8.
2011
|
| 2 | BLS2B, RFXANK
|
| The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.
|
| Naamane H, El Maataoui O, Ailal F, Barakat A, Bennani S, Najib J, Hassar M, Saile R, Bousfiha AA.
|
| Eur J Pediatr 169(9):1069-74. Epub 2010 Apr 23.
2010
|
| 3 | RFX5, RFXANK, RFXAP
|
| DNA binding domain of RFX5: interactions with X-box DNA and RFXANK.
|
| Chakraborty M, Sengupta A, Bhattacharya D, Banerjee S, Chakrabarti A.
|
| Biochim Biophys Acta 1804(10):2016-24. Epub 2010 Jul 13.
2010
|
| 4 | COL1A2, IFNG, RFXANK
|
| RFXB and its splice variant RFXBSV mediate the antagonism between IFNgamma and TGFbeta on COL1A2 transcription in vascular smooth muscle cells.
|
| Fang M, Kong X, Li P, Fang F, Wu X, Bai H, Qi X, Chen Q, Xu Y.
|
| Nucleic Acids Res 37(13):4393-406. Epub 2009 May 22. 2009
|
| 5 | RFX5, RFXANK, RFXAP
|
| Assembly of the RFX complex on the MHCII promoter: role of RFXAP and RFXB in relieving autoinhibition of RFX5.
|
| Garvie CW, Boss JM.
|
| Biochim Biophys Acta 1779(12):797-804. Epub 2008 Aug 6.
2008
|
| 6 | ANKRA2, RFXANK
|
| Class II histone deacetylases confer signal responsiveness to the ankyrin-repeat proteins ANKRA2 and RFXANK.
|
| McKinsey TA, Kuwahara K, Bezprozvannaya S, Olson EN.
|
| Mol Biol Cell 17(1):438-47. Epub 2005 Oct 19.
2006
|
| 7 | ANKRA2, RFXANK
|
| Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases.
|
| Wang AH, Gregoire S, Zika E, Xiao L, Li CS, Li H, Wright KL, Ting JP, Yang XJ.
|
| J Biol Chem 280(32):29117-27. Epub 2005 Jun 17. 2005
|
| 8 | RFXANK
|
| New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
|
| Krawczyk M, Masternak K, Zufferey M, Barras E, Reith W.
|
| Mol Cell Biol 25(19):8607-18. 2005
|
| 9 | BLS2B, RFXANK, ANKRA2
|
| Evolutionary conservation and characterization of the bare lymphocyte syndrome transcription factor RFX-B and its paralogue ANKRA2.
|
| Long AB, Boss JM.
|
| Immunogenetics 56(11):788-97. Epub 2005 Jan 18. 2005
|
| 10 | RFX5, RFXANK, RFXAP
|
| Evolutionary conservation and characterization of the bare lymphocyte syndrome transcription factor RFX-B and its paralogue ANKRA2.
|
| Long AB, Boss JM.
|
| Immunogenetics 56(11):788-97. Epub 2005 Jan 18.
2005
|
| 11 | RFX5, RFXAP, RFXANK
|
| Interferon gamma repression of collagen (COL1A2) transcription is mediated by the RFX5 complex.
|
| Xu Y, Wang L, Buttice G, Sengupta PK, Smith BD.
|
| J Biol Chem 278(49):49134-44. Epub 2003 Sep 10. 2003
|
| 12 | BLS2B, RFXANK
|
| Mutation in a winged-helix DNA-binding motif causes atypical bare lymphocyte syndrome.
|
| Nekrep N, Jabrane-Ferrat N, Wolf HM, Eibl MM, Geyer M, Peterlin BM.
|
| Nat Immunol 3(11):1075-81. Epub 2002 Sep 30. 2002
|
| 13 | RFXANK, BLS2B
|
| RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency.
|
| Nagarajan UM, et al.
|
| Immunity 10(2):153-62. 1999
|
| 14 | BLS2B, RFXANK
|
| A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC Class II deficiency patients.
|
| Masternak K, et al.
|
| Nat Genet 20 : 273-277. 1998
|
| 15 | BLS2A, BLS2B, CIITA, RFXANK
|
| Two complementation groups account for most cases of inherited MHC class II deficiency.
|
| Lisowska-Grospierre B, et al.
|
| Hum Mol Genet 3 : 953-958. 1994
|